Evidence map›Paper›PMID 26636037›Full record

ArticleFrontiers in oncology2015

Corrigendum: Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell Reprogramming: Implications for Hematological Cancers.

Sujatha Muralidharan, Sharath P Sasi, Maria A Zuriaga, Karen K Hirschi, Christopher D Porada, Matthew A Coleman, Kenneth X Walsh, Xinhua Yan, David A Goukassian

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Sujatha MuralidharanWhitaker Cardiovascular Institute, Boston University School of Medicine , Boston, MA , USA.
Sharath P SasiCardiovascular Research Center, GeneSys Research Institute , Boston, MA , USA.
Maria A ZuriagaWhitaker Cardiovascular Institute, Boston University School of Medicine , Boston, MA , USA.
Karen K HirschiYale Cardiovascular Research Center, Yale School of Medicine , New Haven, CT , USA.
Christopher D PoradaWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine , Winston-Salem, NC , USA.
Matthew A ColemanRadiation Oncology, School of Medicine, University of California Davis , Sacramento, CA , USA ; Lawrence Livermore National Laboratory , Livermore, CA , USA.
Kenneth X WalshWhitaker Cardiovascular Institute, Boston University School of Medicine , Boston, MA , USA.
Xinhua YanCardiovascular Research Center, GeneSys Research Institute , Boston, MA , USA ; Tufts University School of Medicine , Boston, MA , USA.
David A GoukassianWhitaker Cardiovascular Institute, Boston University School of Medicine , Boston, MA , USA ; Cardiovascular Research Center, GeneSys Research Institute , Boston, MA , USA ; Tufts University School of Medicine , Boston, MA , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article on p. 231 in vol. 5, PMID: 26528440.].

Indexed as

endogenous reprogramminghematological cancerHSCprogenitorsradiation

Identifiers

PMID26636037
PMCPMC4658418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.